Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regime and formulations for type B adenoviruses

Dosing regime and formulations for type B adenoviruses

US Patent 12350302 · Granted Jul 8, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adenovirus armed with bispecific T cell engager2025
Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell enga2024
Oncolytic adenoviruses armed with heterologous genes2024
Method for permeabilizing tumor vasculature using a tumor vasculature permeabili2023
Oncolytic adenoviruses armed with heterologous genes2022
Dosing regime and formulations for type B adenovirus2021
Dosing regime and formulations for type B adenovirus2021
Dosing regime and formulations for type B adenovirus2021
Oncolytic adenoviruses armed with heterologous genes2018
Prevention and treatment of sarcopenia2014
Modified virus2014
Modification of biological elements2007